| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/23/2013 | WO2013071865A1 Kinase modulating compounds, compositions containing the same and use thereof |
| 05/23/2013 | WO2013071697A1 Aminoquinazoline derivatives and their salts and methods of use |
| 05/23/2013 | WO2013049591A3 Dual inhibitor compounds and methods of use thereof |
| 05/23/2013 | WO2013040535A3 Bicarbocyclic and tricarbocyclic ethynyl derivatives and uses of same |
| 05/23/2013 | US20130131349 Process for producing amide compound |
| 05/23/2013 | US20130131348 Process for producing amide compound |
| 05/23/2013 | US20130131347 Process for Preparing Pyridyl-Substituted Pyrazoles |
| 05/23/2013 | US20130131342 Agent exhibiting the properties of a cognitive function promoter (embodiments) |
| 05/23/2013 | US20130131338 Substituted diketopiperazines as oxytocin antagonists |
| 05/23/2013 | US20130131119 N-[(het)arylethyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues |
| 05/23/2013 | US20130131114 Novel alkene oxindole derivatives |
| 05/23/2013 | US20130131113 Pyridone glucokinase activators |
| 05/23/2013 | US20130131112 Salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione and derivatives thereof, or polymorphs of salts, process for preparing same and use thereof |
| 05/23/2013 | US20130131106 Bifunctional rho kinase inhibitor compounds, composition and use |
| 05/23/2013 | US20130131105 Hcv protease inhibitors and uses thereof |
| 05/23/2013 | US20130131096 8-hydroxy-quinoline derivatives |
| 05/23/2013 | US20130131092 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 05/23/2013 | US20130131084 Use of derivatives of indoles for the treatment of cancer |
| 05/23/2013 | US20130131082 Aminopyrazine Derivative and Medicine |
| 05/23/2013 | US20130131078 Carboxamide Compounds And Methods For Using The Same |
| 05/23/2013 | US20130131074 Pyridone and pyridazone analogues as gpr119 modulators |
| 05/23/2013 | US20130131062 Pyridazinones and furan-containing compounds |
| 05/23/2013 | US20130131061 Novel Estrogen Receptor Ligands |
| 05/23/2013 | US20130131059 Method for treating ophthalmic diseases using kinase inhibitor compounds in prodrug forms |
| 05/23/2013 | US20130131056 Positive allosteric modulators (pam) |
| 05/23/2013 | US20130131052 Amelioration Of The Development Of Cataracts And Other Ophthalmic Diseases |
| 05/23/2013 | US20130131047 Pharmacokinetically improved compounds |
| 05/23/2013 | US20130131040 Pyrazine kinase inhibitors |
| 05/23/2013 | US20130131037 2-(heterocyclylbenzyl)pyridazinone derivatives |
| 05/23/2013 | US20130131036 Novel trpv3 modulators |
| 05/23/2013 | US20130131035 Carboxamides as inhibitors of voltage-gated sodium channels |
| 05/23/2013 | US20130131034 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 05/23/2013 | US20130131018 Substituted isoquinolines and their use as tubulin polymerization inhibitors |
| 05/23/2013 | US20130131015 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives |
| 05/23/2013 | US20130126856 Compound having indenocarbazole ring structure, and organic electroluminescent device |
| 05/23/2013 | US20130126429 Amine sulfide scavengers, methods of using, and methods of making |
| 05/23/2013 | US20130125887 Crystalline forms of a biphenyl compound |
| 05/23/2013 | CA2856291A1 Inhibitors of c-jun-n-terminal kinase (jnk) |
| 05/23/2013 | CA2856103A1 Morpholinyl benzotriazine for use in cancer therapy |
| 05/23/2013 | CA2856076A1 Muscarinic m1 receptor agonists |
| 05/23/2013 | CA2855950A1 Kinase modulating compounds, compositions containing the same and use thereof |
| 05/23/2013 | CA2855009A1 Substituted cyclopropyl compounds useful as gpr119 agonists |
| 05/23/2013 | CA2852697A1 Uracil derivatives as axl and c-met kinase inhibitors |
| 05/23/2013 | CA2851151A1 Aminoquinazoline derivatives and their salts and methods of use |
| 05/22/2013 | EP2594567A1 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof |
| 05/22/2013 | EP2594566A1 Nitrogenated aromatic heterocyclic ring derivative |
| 05/22/2013 | EP2594558A1 Complex compound and optical recording medium containing same |
| 05/22/2013 | EP2593447A2 New heterocyclic compounds as pesticides |
| 05/22/2013 | EP2593435A1 Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives |
| 05/22/2013 | EP2593434A1 Pyridine compounds as sodium channel blockers |
| 05/22/2013 | EP2593432A1 N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors |
| 05/22/2013 | EP2592934A1 Novel dihydropyridin-2(1h)-one compounds as s-nitrosoglutathione reductase inhibitors and neurokinin-3 receptor antagonists |
| 05/22/2013 | EP2592933A1 Mif inhibitors and their uses |
| 05/22/2013 | CN1993339B Aromatic compounds |
| 05/22/2013 | CN103119045A Pyrrolopyrimidine compounds and uses thereof |
| 05/22/2013 | CN103119042A Novel heterocyclic compound, and composition for treating inflammatory diseases using same |
| 05/22/2013 | CN103119036A Heterocyclic compounds as agents for pest control |
| 05/22/2013 | CN103119035A Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors |
| 05/22/2013 | CN103119034A Novel heterocyclic compounds as pest control agents |
| 05/22/2013 | CN103119028A 1,2,4-Triazolone Derivative |
| 05/22/2013 | CN103119025A Pyrimidine compounds as inhibitors of protein kinases ikk epsilon and/or tbk-1, processes for their preparation, and pharmaceutical compositions containing them |
| 05/22/2013 | CN103119021A Anti-inflammatory agents |
| 05/22/2013 | CN103118680A Heteroarylmethyl amides |
| 05/22/2013 | CN103113355A Bcr/Abl tyrosine kinase inhibitor as well as preparation method and application thereof in treating chronic granulocytic leukemia |
| 05/22/2013 | CN103113353A Triazole compounds, medical composition thereof and preparation and application of triazole compounds |
| 05/22/2013 | CN103113352A Method for preparing fasudil impurity-homopiperazine disulfone |
| 05/22/2013 | CN103113351A Method for preparing optically pure chiral sulfoxide compound |
| 05/22/2013 | CN103113350A Novel crystal form of R-rabeprazole sodium hydrate, preparation method and application thereof |
| 05/22/2013 | CN103113349A 4-imidazolyl quinoline and quinazoline ketone aromatizing enzyme inhibitors as well as preparation method and medical application thereof |
| 05/22/2013 | CN103113348A Pseudo-polymorphic form of desloratadine citrate disodium and preparation method thereof |
| 05/22/2013 | CN103113303A Nitrogen heterocyclic compound used as CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells) receptor antagonist |
| 05/22/2013 | CN103109816A Thiobenzamide compounds and application thereof |
| 05/22/2013 | CN102321070B Method for preparing imatinib methylolsulfonate alpha crystal through inverse solvent recrystallization method |
| 05/22/2013 | CN102137844B Compounds and compositions as modulators of GPR119 activity |
| 05/22/2013 | CN102134214B Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 05/22/2013 | CN102020634B Preparation method of N-(w-cyanoalkyl) benzamide compounds |
| 05/22/2013 | CN101939313B 3,8-diaminotetrahydroquinoline derivative |
| 05/22/2013 | CN101835756B 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive MGLUR2 -receptor modulators |
| 05/22/2013 | CN101821257B 5-HT7 receptor antagonists |
| 05/22/2013 | CN101622241B Benzimidazole compound and pharmaceutical use thereof |
| 05/22/2013 | CN101479250B Tetrazole-substituted arylamides |
| 05/22/2013 | CN101316823B 2,4,5-triphenyl imidazoline derivatives as inhibitors of interaction between p53 and MDM2 proteins for use as anticancer agents |
| 05/21/2013 | US8445694 Hydrazonopyrazole derivatives and their use as therapeutics |
| 05/21/2013 | US8445684 Nicotinic acetylcholine receptor ligands and the uses thereof |
| 05/21/2013 | US8445683 Porphyrin compounds comprising one or more pyridone moieties |
| 05/21/2013 | US8445674 Heterocyclyl compounds |
| 05/21/2013 | US8445525 Carboxylic acid amides, the preparation thereof and their use as medicaments |
| 05/21/2013 | US8445518 Triazolyl pyridyl benzenesulfonamides |
| 05/21/2013 | US8445515 C5aR antagonists |
| 05/21/2013 | US8445514 Urotensin II receptor antagonists |
| 05/21/2013 | US8445496 Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the same |
| 05/21/2013 | US8445494 Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| 05/21/2013 | US8445493 Tetrasubstituted pyridazines hedgehog pathway antagonists |
| 05/21/2013 | US8445491 Wnt protein signalling inhibitors |
| 05/21/2013 | US8445480 CETP inhibitors derived from benzoxazole arylamides |
| 05/21/2013 | US8445477 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 05/21/2013 | US8445476 Carbacephem β-lactam antibiotics |
| 05/21/2013 | CA2573223C Aromatic compound |
| 05/21/2013 | CA2560162C Inhibitors of iap |
| 05/16/2013 | WO2013071203A1 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators |